Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Residues in Transmembrane Domains I and II Determine γ-Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide

S.A. Thompson, S.A. Arden, G. Marshall, P.B. Wingrove, P.J. Whiting and K.A. Wafford
Molecular Pharmacology June 1999, 55 (6) 993-999; DOI: https://doi.org/10.1124/mol.55.6.993
S.A. Thompson
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.A. Arden
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Marshall
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.B. Wingrove
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.J. Whiting
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.A. Wafford
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 55 no. 6 993-999
DOI 
https://doi.org/10.1124/mol.55.6.993
PubMed 
10347239

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received September 28, 1998
  • Accepted March 24, 1999
  • Published online June 1, 1999.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. S.A. Thompson,
  2. S.A. Arden,
  3. G. Marshall,
  4. P.B. Wingrove,
  5. P.J. Whiting, and
  6. K.A. Wafford
  1. Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, United Kingdom
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 1999 to September 2023

AbstractFullPdf
May 1999211724
Jun 1999306439
Jul 199962724
Aug 19993168
Sep 19992128
Oct 1999074
Nov 19992115
Dec 1999082
Jan 20000105
Feb 2000293
Mar 20001117
Apr 20000104
May 2000264
Jun 2000038
Jul 20001108
Aug 200001111
Sep 20002316
Oct 2000359
Nov 20000612
Dec 2000011
Jan 2001145
Feb 2001066
Mar 20012812
Apr 2001145
May 2001283
Jun 2001188
Jul 2001149
Aug 2001182
Sep 2001088
Oct 2001169
Nov 2001216
Dec 2001034
Jan 20020812
Feb 2002085
Mar 2002139
Apr 2002135
May 2002022
Jun 2002141
Jul 2002042
Aug 2002254
Sep 2002062
Oct 2002134
Nov 2002148
Dec 2002032
Jan 2003023
Feb 2003153
Mar 2003223
Apr 2003047
May 200301415
Jun 2003186
Jul 20038125
Aug 200310100
Sep 20038178
Oct 20037165
Nov 200311175
Dec 200312338
Jan 200416144
Feb 20047133
Mar 200412145
Apr 20046257
May 2004892
Jun 2004142710
Jul 200415202
Aug 200415172
Sep 200413167
Oct 200413192
Nov 20048252
Dec 2004491
Jan 200513202
Feb 20059217
Mar 200511114
Apr 20053144
May 2005583
Jun 20058112
Jul 200510194
Aug 200551510
Sep 2005174
Oct 20053156
Nov 20055107
Dec 2005492
Jan 20062104
Feb 200682811
Mar 2006494
Apr 2006143
May 2006021
Jun 2006384
Jul 2006262
Aug 2006364
Sep 20062104
Oct 2006161
Nov 20063156
Dec 2006031
Jan 2007081
Feb 20071155
Mar 20071135
Apr 20073156
May 20071167
Jun 20071112
Jul 2007150
Aug 20071162
Sep 2007273
Oct 2007254
Nov 2007460
Dec 2007042
Jan 2008133
Feb 2008046
Mar 2008446
Apr 2008442
May 2008278
Jun 2008343
Jul 2008297
Aug 2008161
Sep 2008742
Oct 2008634
Nov 2008313
Dec 2008332
Jan 2009244
Feb 2009244
Mar 2009464
Apr 2009132
May 2009023
Jun 2009254
Jul 2009222
Aug 2009186
Sep 2009896
Oct 2009510
Nov 2009200
Dec 2009300
Jan 2010211
Feb 2010455
Mar 2010403
Apr 2010042
May 2010682
Jun 2010583
Jul 2010421
Aug 2010176
Sep 2010527
Oct 201021110
Nov 2010052
Dec 2010663
Jan 2011774
Feb 2011492
Mar 20119119
Apr 2011624
May 2011242
Jun 2011657
Jul 20112367
Aug 20111179
Sep 2011535
Oct 201111106
Nov 2011783
Dec 2011176
Jan 20128910
Feb 20121075
Mar 2012538
Apr 2012626
May 20125810
Jun 20121333
Jul 2012735
Aug 2012699
Sep 2012759
Oct 2012161111
Nov 20121095
Dec 20121476
Jan 20131147
Feb 2013101111
Mar 201316119
Apr 2013847
May 2013796
Jun 2013322
Jul 2013236
Aug 2013855
Sep 2013802
Oct 20131042
Nov 2013258
Dec 2013625
Jan 20141111
Feb 2014610
Mar 2014132
Apr 2014753
May 2014378
Jun 2014142
Jul 2014366
Aug 2014461
Sep 2014474
Oct 2014552
Nov 2014543
Dec 20141942
Jan 2015542
Feb 2015130
Mar 2015231
Apr 2015254
May 2015520
Jun 2015662
Jul 20156113
Aug 2015050
Sep 2015131
Oct 2015031
Nov 2015232
Dec 20151255
Jan 2016635
Feb 20163784
Mar 20161736
Apr 2016305
May 20161823
Jun 2016350
Jul 20166123
Aug 2016172
Sep 2016644
Oct 20161100
Nov 2016282
Dec 2016070
Jan 2017144
Feb 2017061
Mar 2017080
Apr 2017061
May 2017170
Jun 20170140
Jul 2017060
Aug 2017281
Sep 20170172
Oct 20170116
Nov 20173172
Dec 2017571
Jan 20181142
Feb 20183123
Mar 20185122
Apr 20180228
May 20182142
Jun 20184112
Jul 20180133
Aug 2018053
Sep 20180283
Oct 20180133
Nov 20180113
Dec 2018422
Jan 20191123
Feb 2019621
Mar 2019700
Apr 20191022
May 2019311
Jun 2019502
Jul 2019500
Aug 2019321
Sep 2019900
Oct 2019631
Nov 20191700
Dec 20191221
Jan 2020621
Feb 2020511
Mar 2020830
Apr 2020100
Jun 2020210
Jul 2020510
Aug 2020003
Sep 2020010
Oct 2020422
Nov 2020800
Dec 2020940
Jan 202112153
Feb 20219132
Mar 2021731
Apr 20211111
May 20212352
Jun 2021470
Jul 2021731
Aug 2021571
Sep 2021530
Oct 2021910
Nov 2021910
Dec 2021821
Jan 20221220
Feb 2022311
Mar 20221311
Apr 2022700
May 2022542
Jun 2022831
Jul 2022710
Aug 20221420
Sep 2022693
Oct 2022940
Nov 20221810
Dec 2022921
Jan 2023330
Feb 2023340
Mar 20231010
Apr 20231011
May 2023710
Jun 2023710
Jul 20231430
Aug 2023220
Sep 2023550

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 55 (6)
Molecular Pharmacology
Vol. 55, Issue 6
1 Jun 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Residues in Transmembrane Domains I and II Determine γ-Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Residues in Transmembrane Domains I and II Determine γ-Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide

S.A. Thompson, S.A. Arden, G. Marshall, P.B. Wingrove, P.J. Whiting and K.A. Wafford
Molecular Pharmacology June 1, 1999, 55 (6) 993-999; DOI: https://doi.org/10.1124/mol.55.6.993

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Residues in Transmembrane Domains I and II Determine γ-Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide

S.A. Thompson, S.A. Arden, G. Marshall, P.B. Wingrove, P.J. Whiting and K.A. Wafford
Molecular Pharmacology June 1, 1999, 55 (6) 993-999; DOI: https://doi.org/10.1124/mol.55.6.993
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics